// App-Quantinova.ai

17600 : Carvedilol Improves Left and Right Ventricular Fibrosis and Function Through Abrogation of Tgf?1-ctgf Signaling in a Rat Persistent Right Ventricular Afterload Model

Researchers

Presenter

  • Hideyuki Kato

Principal Investigators

  • Osami Honjo

  • Mei Sun

  • Mark K Friedberg

Medical Centers

  • Osaka Rousai Hospital, Osaka, Japan

  • Hospital for Sick Children, Toronto, ON, Canada

Locations

  • Canada

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • N/A

Drug/Treatment

  • Monocrotaline

  • Carvedilol

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved